Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207908 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy
A Phase 1 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT01207908 is a Phase 1 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 44 participants.
The verdict
NCT01207908, a Phase 1 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether IGF-1 therapy improves or preserves muscle function in Duchenne Muscular Dystrophy (DMD).
Interventions
- DRUG IGF-1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01207908
The ClinicalTrials.gov registry entry for NCT01207908 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IGF-1 is the first listed.
NCT01207908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01207908 about?
NCT01207908 is a clinical study titled "Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy". The purpose of this study is to determine whether IGF-1 therapy improves or preserves muscle function in Duchenne Muscular Dystrophy (DMD).
What is the current status of trial NCT01207908?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2010-11. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01207908?
The interventions under investigation include: IGF-1 (DRUG).
Who is sponsoring clinical trial NCT01207908?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.